Suresh K. Tipparaju
Merrimack Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Axon Guidance and Neuronal Signaling, Cancer therapeutics and mechanisms, Nanoparticle-Based Drug Delivery, Monoclonal and Polyclonal Antibodies Research, Tuberculosis Research and Epidemiology
Most-Cited Works
- → Indoleamides are active against drug-resistant Mycobacterium tuberculosis(2013)151 cited
- → Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains(2013)123 cited
- → In Pursuit of Natural Product Leads: Synthesis and Biological Evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4-carboxylic acid (A-33853) and Its Analogues: Discovery of N-(2-Benzoxazol-2-ylphenyl)benzamides as Novel Antileishmanial Chemotypes(2008)75 cited
- → Pyrido[1,2‐a]benzimidazole‐Based Agents Active Against Tuberculosis (TB), Multidrug‐Resistant (MDR) TB and Extensively Drug‐Resistant (XDR) TB(2011)65 cited
- → Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models(2019)59 cited
- → Identification and Development of Novel Inhibitors of Toxoplasma gondii Enoyl Reductase(2010)50 cited
- → Design and Synthesis of Aryl Ether Inhibitors of the Bacillus Anthracis Enoyl‐ACP Reductase(2008)45 cited
- → Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs(2019)42 cited
- → Design and synthesis of 2-pyridones as novel inhibitors of the Bacillus anthracis enoyl-ACP reductase(2008)32 cited
- → Natural product leads for drug discovery: Isolation, synthesis and biological evaluation of 6-cyano-5-methoxyindolo[2,3-a]carbazole based ligands as antibacterial agents(2009)23 cited